9
Participants
Start Date
March 31, 2012
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
Acitretin
All patients will receive open-label single oral acitretin 10 mg capsule once daily as a starting dose. If well tolerated, the dose will be increased in the first 4 weeks to a maximum of 30mg/day. Patients will be instructed to take the treatment as a single oral dose with a meal.
Windsor Clinical Research Inc., Windsor
Innovaderm Research Inc., Montreal
Lead Sponsor
Collaborators (1)
Tribute Pharmaceuticals
INDUSTRY
Innovaderm Research Inc.
OTHER